EVENTS

pharma.be info session - Clinical Trials: result of the pilot projects and workshop

Date:
19/03/2018
Time:
14:00 - 17:00
Location:
Pharma.be Forum, 1170 Bruxelles, 166 chaussée de La Hulpe, Belgium
Type:
Info session Clinical Trial: result of the pilot projects and workshop

 

 

 

On the 19th of March pm, we need your voice to ensure the competitive position of Belgium for clinical trials!

Dear Members,

Last year, pharma.be has initiated with Deloitte Services L.P. a study to better understand the footprint of clinical trials of which the first results will be presented in a dedicated workshop. Based on this analysis, you will be able to share your thoughts and experiences on a selection of challenges in the future for clinical trials.

Mrs. Greet Musch, Director General at The Federal Agency of Medicines, will assist to the session.

We hope to see you at this event to lay the foundations of the future of the clinical trials in Belgium.

Catherine Rutten
CEO pharma.be

 

Clinical Trials: result of the pilot projects and workshop

19-03-2018
14.00 - 14.05
Welcome and introduction by Catherine Rutten Speaker : Mrs Mrs. Catherine Rutten
CEO of pharma.be
14.05 - 15.00
The footprint of clinical trials: results of the Deloitte survey Speaker : Mrs Mrs. Tessa Van Montfort
Senior Consultant at Monitor Deloitte
15.00 - 15.40
Challenges in the future for clinical trials: dedicated workshops
15.40 - 16.00
Presentation of the conclusions of the workshops in presence of Mrs. Greet Musch, Director General of AFMPS
16.00 - 16.05
Conclusions Speaker : Dr Dr. Stefaan Vancayzeele
Chair of the pharma.be Clinical Trials Taskforce - Chief Scientific Officer - Novartis Belgium